BIOMAT Database Logo BIOMAT Database Logo

[Irritable colon syndrome: therapeutic activity of otilonium bromide alone or in combination with benzodiazepine. Controlled double-blind study]. 1984

M Tarquini, and L Sannino, and G Bazuro, and M Palomba, and C Ricci, and M Koch, and P Fracasso, and L Capurso

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003109 Colonic Diseases, Functional Chronic or recurrent colonic disorders without an identifiable structural or biochemical explanation. The widely recognized IRRITABLE BOWEL SYNDROME falls into this category. Functional Colonic Diseases,Colonic Disease, Functional,Disease, Functional Colonic,Diseases, Functional Colonic,Functional Colonic Disease
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Tarquini, and L Sannino, and G Bazuro, and M Palomba, and C Ricci, and M Koch, and P Fracasso, and L Capurso
[The otilonium bromide-benzodiazepine combination in the therapy of the irritable colon syndrome].
August 1992, La Clinica terapeutica,
M Tarquini, and L Sannino, and G Bazuro, and M Palomba, and C Ricci, and M Koch, and P Fracasso, and L Capurso
Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study.
October 1998, Alimentary pharmacology & therapeutics,
M Tarquini, and L Sannino, and G Bazuro, and M Palomba, and C Ricci, and M Koch, and P Fracasso, and L Capurso
[Otilonium bromide-diazepam in the treatment of the irritable colon. A controlled study versus otilonium bromide].
August 1992, La Clinica terapeutica,
M Tarquini, and L Sannino, and G Bazuro, and M Palomba, and C Ricci, and M Koch, and P Fracasso, and L Capurso
Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome.
December 2002, European journal of gastroenterology & hepatology,
M Tarquini, and L Sannino, and G Bazuro, and M Palomba, and C Ricci, and M Koch, and P Fracasso, and L Capurso
Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.
September 2014, World journal of gastroenterology,
M Tarquini, and L Sannino, and G Bazuro, and M Palomba, and C Ricci, and M Koch, and P Fracasso, and L Capurso
Irritable bowel syndrome: focus on otilonium bromide.
February 2014, Expert review of gastroenterology & hepatology,
M Tarquini, and L Sannino, and G Bazuro, and M Palomba, and C Ricci, and M Koch, and P Fracasso, and L Capurso
Is otilonium bromide globally effective in irritable bowel syndrome?
October 2011, Alimentary pharmacology & therapeutics,
M Tarquini, and L Sannino, and G Bazuro, and M Palomba, and C Ricci, and M Koch, and P Fracasso, and L Capurso
Mebeverine in patients with the irritable colon syndrome: double blind study.
April 1973, The New Zealand medical journal,
M Tarquini, and L Sannino, and G Bazuro, and M Palomba, and C Ricci, and M Koch, and P Fracasso, and L Capurso
Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysis.
March 2017, Therapeutic advances in gastroenterology,
M Tarquini, and L Sannino, and G Bazuro, and M Palomba, and C Ricci, and M Koch, and P Fracasso, and L Capurso
The evaluation of otilonium bromide treatment in asian patients with irritable bowel syndrome.
October 2011, Journal of neurogastroenterology and motility,
Copied contents to your clipboard!